The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type

被引:123
作者
Weigelt, Britta [1 ]
Geyer, Felipe C. [2 ]
Natrajan, Rachael [2 ]
Lopez-Garcia, Maria A. [2 ,3 ]
Ahmad, Amar S. [2 ]
Savage, Kay [2 ]
Kreike, Bas [1 ]
Reis-Filho, Jorge S. [2 ]
机构
[1] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands
[2] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Mol Pathol Team, London SW3 6JB, England
[3] Univ Hosp Virgen Rocio, Dept Pathol, Seville, Spain
关键词
breast cancer; microarrays; invasive lobular carcinoma; invasive ductal carcinoma; caveolin-1; E-CADHERIN/CATENIN COMPLEX; GENE-EXPRESSION PATTERNS; BREAST-CANCER; BASAL-LIKE; IN-SITU; NEOADJUVANT CHEMOTHERAPY; CAVEOLIN-1; NEOPLASIA; TUMORS; DIFFERENTIATION;
D O I
10.1002/path.2629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Invasive lobular carcinoma (ILC) is the most frequent special type of breast cancer. The majority of these tumours are of low histological grade, express hormone receptors, and lack HER2 expression. The pleomorphic variant of ILCs (PLCs) is characterized by atypical cells with pleomorphic nuclei and is reported to have an aggressive clinical behaviour. Expression profiling studies have demonstrated that classic ILCs preferentially display a luminal phenotype, whereas PLCs may be of luminal, HER2 or molecular apocrine subtypes. The aims of this study were two-fold: to determine the transcriptomic characteristics of lobular carcinomas and to define the genome-wide transcriptomic differences between classic ILCs and PLCs. To define the transcriptomic characteristics of ILCs, minimizing the impact of histological grade and molecular subtype on the analysis, we subjected a series of grade- and molecular subtype-matched ILCs and invasive ductal carcinomas (IDCs) to genome-wide gene expression profiling using oligonucleotide microarrays. Hierarchical clustering analysis demonstrated that ILCs formed a separate cluster and a supervised analysis revealed that 5.8% of the transcriptionally regulated genes were significantly differentially expressed in ILCs compared to grade- and molecular subtype-matched IDCs. ILCs displayed down-regulation of E-cadherin and of genes related to actin cytoskeleton remodelling. protein ubiquitin, DNA repair, cell adhesion, TGF-beta signalling; and up-regulation of transcription factors/immediate early genes, lipid/prostaglandin biosynthesis genes, and cell migration-associated genes. Supervised analysis of classic ILCs and PLCs demonstrated that less than 0.1% of genes were significantly differentially expressed between these tumour subtypes. Our results demonstrate that ILCs differ from grade- and molecular subtype-matched IDCs in the expression of genes related to cell adhesion, cell-to-cell signalling, and actin cytoskeleton signalling. However, classic ILCs and PLCs are remarkably similar at the molecular level and should be considered as part of a spectrum of lesions. Copyright (C) 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:45 / 57
页数:13
相关论文
共 57 条
[1]   Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: Further evidence to support the concept of low nuclear grade breast neoplasia family [J].
Abdel-Fatah, Tarek M. A. ;
Powe, Desmond G. ;
Hodi, Zsolt ;
Reis-Filho, Jorge S. ;
Lee, Andrew H. S. ;
Ellis, Ian O. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (04) :513-523
[2]   High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma [J].
Abdel-Fatah, Tarek M. A. ;
Powe, Desmond G. ;
Hodi, Zsolt ;
Lee, Andrew H. S. ;
Reis-Filho, Jorge S. ;
Ellis, Ian O. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (03) :417-426
[3]   Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome [J].
Arpino, G ;
Bardou, VJ ;
Clark, GM ;
Elledge, RM .
BREAST CANCER RESEARCH, 2004, 6 (03) :R149-R156
[4]   Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines [J].
Arriola, Edurne ;
Marchio, Caterina ;
Tan, David Sp ;
Drury, Suzanne C. ;
Lambros, Maryou B. ;
Natrajan, Rachael ;
Rodriguez-Pinilla, Socorro Maria ;
Mackay, Alan ;
Tamber, Narinder ;
Fenwick, Kerry ;
Jones, Chris ;
Dowsett, Mitch ;
Ashworth, Alan ;
Reis-Filho, Jorge S. .
LABORATORY INVESTIGATION, 2008, 88 (05) :491-503
[5]   Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles [J].
Bertucci, F. ;
Orsetti, B. ;
Negre, V. ;
Finetti, P. ;
Rouge, C. ;
Ahomadegbe, J-C ;
Bibeau, F. ;
Mathieu, M-C ;
Treilleux, I. ;
Jacquemier, J. ;
Ursule, L. ;
Martinec, A. ;
Wang, Q. ;
Benard, J. ;
Puisieux, A. ;
Birnbaum, D. ;
Theillet, C. .
ONCOGENE, 2008, 27 (40) :5359-5372
[6]   Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas [J].
Berx, G ;
Nollet, F ;
Van Roy, F .
CELL ADHESION AND COMMUNICATION, 1998, 6 (2-3) :171-184
[7]   E-cadherin is a tumour invasion suppressor gene mutated in human lobular breast cancers [J].
Berx, G ;
CletonJansen, AM ;
Nollet, F ;
deLeeuw, WJF ;
vandeVijver, MJ ;
Cornelisse, C ;
vanRoy, F .
EMBO JOURNAL, 1995, 14 (24) :6107-6115
[8]   Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma May Not Improve Rates of Breast Conservation [J].
Boughey, Judy C. ;
Wagner, Jamie ;
Garrett, Betsy J. ;
Harker, Lori ;
Middleton, Lavinia P. ;
Babiera, Gildy V. ;
Meric-Bernstam, Funda ;
Lucci, Anthony ;
Hunt, Kelly K. ;
Bedrosian, Isabelle .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (06) :1606-1611
[9]   Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma [J].
Cocquyt, VF ;
Blondeel, PN ;
Depypere, HT ;
Praet, MM ;
Schelfhout, VR ;
Silva, OE ;
Hurley, J ;
Serreyn, RF ;
Daems, KK ;
Van Belle, SJP .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (04) :361-367
[10]   Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes [J].
Cristofanilli, M ;
Gonzalez-Angulo, A ;
Sneige, N ;
Kau, SW ;
Broglio, K ;
Theriault, RL ;
Valero, V ;
Buzdar, AU ;
Kuerer, H ;
Buccholz, TA ;
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :41-48